Oncopeptides seeks US FDA accelerated approval for melflufen in combo with dexamethasone to treat multiple myeloma

MLA

“Oncopeptides Seeks US FDA Accelerated Approval for Melflufen in Combo with Dexamethasone to Treat Multiple Myeloma.” PharmaBiz, July 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.628303635&authtype=sso&custid=ns315887.

APA

Oncopeptides seeks US FDA accelerated approval for melflufen in combo with dexamethasone to treat multiple myeloma. (2020, July 2). PharmaBiz.

Chicago

PharmaBiz. 2020. “Oncopeptides Seeks US FDA Accelerated Approval for Melflufen in Combo with Dexamethasone to Treat Multiple Myeloma,” July 2. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.628303635&authtype=sso&custid=ns315887.